Announced Fri, 15 May, 2026 · 21:25 IST

The Appointment of Ms. Tania Mazumdar as Chief Executive Officer (CEO) and Key Managerial Personnel (KMP)of the company.

Ceo Appointed ExternalManagement Changes View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-3.6%Reaction day
₹26.43
prior close
₹26.52
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-1.4%-2.2% vs market
Healthcare Services peers, median of 61sector · industry level-0.8%-2.8% vs sector

On the reaction day the stock moved 2.2 pts less than Nifty Microcap 250 and 2.8 pts less than its Healthcare Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.4
10m
-6.8
15m
-6.8
30m
-7.2
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-3.6-1.4-2.2-0.8-2.8
Next day
-0.5-0.9+0.5+0.0-0.5
2d
+2.2-0.3+2.5+0.2+2.0
3d
-4.0+0.8-4.8+0.8-4.8
4d
-8.8+0.9-9.6+0.3-9.1
5d
-13.3+2.5-15.8+0.9-14.2
1w
-13.5+3.1-16.7+0.8-14.4
15d
-12.2+3.5-15.7+1.9-14.2
1m
-0.5+8.0-8.5+2.4-2.9
2m
-6.2+9.3-15.5+2.3-8.5
3m
+36.0+14.0+22.0+5.1+30.9
UpDownMarket · Nifty Microcap 250Sector · Healthcare Services peers, median of 61Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Globalspace Technologies has appointed Ms. Tania Mazumdar as Chief Executive Officer and Key Managerial Personnel effective May 15, 2026, for a term of 3 years. She brings 22+ years of experience in pharmaceutical, diagnostics, and digital health sectors, with expertise in strategic growth, commercial transformation, and innovation. The appointment was approved at the Board meeting held on May 15, 2026. Ms. Mazumdar is not related to any existing director of the company. The same Board meeting also approved audited financial results for FY2026 showing standalone net profit of Rs 136.49 lakhs and declared an equity commitment of Rs 1,144.33 lakhs towards Miljon Medi App Pvt Ltd pending share allotment.

Likely market impact

The appointment of an experienced external CEO from the pharmaceutical and digital health sector signals potential strategic focus on healthcare solutions and business growth, which could be viewed positively by investors looking for operational turnaround or sector expansion.